Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
There are a variety of hepatitis C treatments offered for all genotypes, with various stages of liver damage.
Ask Hep discusses the ins and outs of multiple hepatitis C genotypes.
The presence of less studied HCV genotypes may compromise cure rates.
The hepatitis C virus has different types or virus strains called genotypes. Each genotype has a unique genetic makeup; some have subtypes.
We aren’t sure how many people have more than one hep C genotype, which is called mixed genotypes.
Researchers have discovered a new hepatitis C genotype.
There are three parts to testing for hepatitis C virus (HCV).
The Food and Drug Administration has approved AbbVie’s once-daily Mavyret to treat all six major genotypes of hepatitis C virus (HCV).
It approved 12 weeks of Gilead Sciences’ Vosevi for the re-treatment of adults with all genotypes of HCV who do not have cirrhorsis.
An analysis of forty-two clinical trials of all the approved direct acting antiviral HCV regimens.
A look at the importance of the hepatitis C genotype test.
The triple-drug combo would be the first once-daily, single-tablet regimen for those with all genotypes who’ve failed a previous treatment.
AbbVie’s combination treatment of ABT-493 and ABT-530 has boasted high cure rates among all genotypes of hepatitis C virus.
The FDA has granted priority review status to Gilead’s application for approval of a once-daily combo tablet of Sovaldi and velpatasvir.
Getting access to the new hep C drugs remains an ongoing barrier for too many people, but the drugs keep getting better.
Major clinical trials of hepatitis C drugs among those with HIV had very restrictive eligibility, questioning their generalizability.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.